[[alternative]]Critical Factors for the Pharmaceutical Companies in Taiwan to Adopt B2B E-Commerce from Transaction Cost Theory Perspective: Case Study

[[abstract]]目前台灣製藥業的交易模式耗費極大的行銷管理成本，以致難以應付日益競爭的經營環境。因此，透過B2B電子商務來提升營運效率，並降低經營成本已成為台灣製藥廠必須採取的措施。由於目前藥廠導入B2B電子商務之關鍵考量因素的相關文獻不多，使得台灣製藥廠普遍無法經由B2B電子商務來獲取經營效益。本研究從交易成本理論觀點來進行研究並發現：製藥廠對B2B電子商務公平性的信賴度、藥廠對顧客服務的特殊性、顧客訂購藥品的數量、以及交易的不確定性將明顯成為台灣製藥廠導入B2B電子商務的關鍵考量因素；藥品的特殊性、藥品交易頻率的高低雖可能是重要的影響因素，但尚未有足夠的證據支持其為關鍵考量因素。 As the temporal transaction model of the pharmaceutical industry consumes too much marked management cost, it is unable to operate under the more and more competitive domestic environment. To promote the operating efficiency and reducing operating cost, the pharmaceutical industry needs to apply the B2B E-Commerce. However, it is a pity that literatures on the critical factors for the pharmaceutical companies to adopt B2B E-Commerce are so few that the pharmaceutical companies are timid to gain benefits from the B2B E-Commerce. This study investigates the critical factors for the pharmaceutical companies in Taiwan to adopt B2B E-Commerce from transaction cost theory perspective. They are: the reliability on the fairness of B2B E-Commerce, the customer-oriented management policy, the quantity of order from the customers, and the uncertainty of trading itself. It also presents an argument on the specific features of different pharmaceuticals and trading frequency and concludes that they might as well be potential factors, but they are in lack of sufficient supporting evidence